Want to see ENSC full AI Analyst Report?
Ensysce Biosciences (ENSC) Income Statement
Ensysce Biosciences Income Statement
Last quarter (Q2 2026), Ensysce Biosciences's total revenue was $1.16M. In Q2, Ensysce Biosciences's net income was $-2.57M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 10.24M | $ 6.73M | $ 10.72M | $ 24.22M | $ 19.87M | |
| Depreciation and Amortization | $ 6.53K | $ 0.00 | $ 0.00 | $ 0.00 | $ 151.00 |
| $ -10.15M | $ -6.70M | $ -10.27M | $ -24.10M | $ -27.85M | |
| $ -10.24M | $ -6.73M | $ -10.72M | $ -24.22M | $ -19.87M | |
| $ 64.76K | $ -1.26M | $ 91.91K | $ 14.41K | $ -9.28M | |
| $ -10.18M | $ -7.99M | $ -10.63M | $ -24.21M | $ -29.15M | |
| $ -10.18M | $ -7.99M | $ -10.61M | $ -24.17M | $ -29.08M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.98 | $ -4.57 | $ -4.69 | $ -139.44 | $ -355.68 |
| Diluted EPS | $ -3.98 | $ -4.57 | $ -4.69 | $ -139.44 | $ -355.68 |
| Weighted Average Shares Outstanding | 2.56M | 1.75M | 2.26M | 179.93K | 84.02K |
| Weighted Average Shares Outstanding (Diluted) | 25.57M | 1.75M | 2.26M | 179.93K | 84.02K |
Currency in USD